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evaluate plan quality: Paddick conformity index (PCI), gradient index (GI),
and BOT. Heat maps for each of the above metrics as a function of LD and
BOT penalties were analyzed. An objective score matrix was calculated for
each plan using a linear weighted combination of scaled and normalized
GI, PCI, and BOT. An optimal solution space containing the 5 lowest values of the score matrix per patient was extracted. A frequency histogram
was subsequently created in the LD-BOT coordinate space.
Results: The target volumes in the study ranged from 1.0 cc to 2.5 cc. For
every patient, 121 plans were generated across the range of LD and BOT
penalties, resulting in 3630 plans included in this analysis. The range of PCI,
GI, and BOT across all plans were 0.71 to 0.95, 2.5 to 2.9, and 17.2 to 221
minutes, respectively. The variation of the LD/BOT penalties had a much
larger impact resulting in a higher deviation about the mean for BOT (169%),
followed by PCI (28%). Heat map analysis revealed that the plans that maximized PCI and minimized GI values occupied the upper triangular matrix of
the LD/BOT penalty space, while plans that minimized BOT occupied the
lower triangular space. The optimal solutions frequently occupied the diagonal
space in between these zones. Speciﬁcally, the histogram analysis showed that
4 highest frequencies occurred at the user-inputted settings (LD, BOT) of
(0.6, 0.5), (0.8, 0.6), (0.7, 0.5), and (0.7, 0.6), in order of plan quality.
Conclusion: In this study, the user-inputted variables (LD and BOT) were
systematically varied to determine the optimal solutions to simultaneously
maximize PCI while minimizing GI and BOT. The results of this study
may permit SRS planners to generate single brain metastasis plans more
efﬁciently using the study-deﬁned optimal settings of LD and BOT.
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Radiation Oncology, University of Kansas Medical Center, Kansas City, KS
Purpose/Objective(s): Proton minibeam radiation therapy (pMBRT) is a
novel proton modality of spatially fractionated RT (SFRT). pMBRT can
reduce the radiation damage to normal tissues via biological dose sparing
of high peak-to-valley dose ratio (PVDR). This work will develop a new
pMBRT treatment planning method that jointly optimizes the plan quality
and maximizes the PVDR.
Materials/Methods: The new optimization method simultaneously maximizes the normal-tissue PVDR and optimizes the dose distribution at tumor
targets and organs-at-risk (OAR). The PVDR maximization is through the
joint total variation (TV) and L1 regularization with respect to the normal-tissue dose. That is, at beam-eye-view projected dose slices of several depths for
each beam angle, the TV of dose is maximized, corresponding to the PVDR
maximization, while the L1 of dose is minimized, corresponding to the minimization of the OAR dose and maximization of survival fraction (SF).
Results: The new IMPT method with TV and L1 regularization (TVL1)
was validated in comparison with the conventional IMPT method (CONV)
for pMBRT on several clinical cases. The results show that TVL1 provided
larger PVDR and SF than CONV for biological sparing of normal tissues,
with preserved plan quality in terms of physical dose distribution.
Conclusion: A new pMBRT treatment planning method is developed that
can optimize and improve normal-tissue PVDR and SF, by incorporating
TV and L1 dose regularization into IMPT.
Author Disclosure: W. Zhang: None. W. Li: None. Y. Lin: None. F.
Wang: None. R.C. Chen: Consultant; Accuray Inc, AbbVie, Astellas, Janssen. Advisory Board; Myovant. H. Gao: None.
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1
Department of Radiation Oncology, Henry Ford Cancer Institute, Detroit,
MI, 2Varian Medical Systems, Palo Alto, CA, 3Varian Medical Systems, Palo
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Purpose/Objective(s): Recent research efforts utilizing knowledge-based
treatment planning for the prediction of 3D radiation dose distributions
from planning structure sets have achieved positive results. Most ongoing
efforts to generate deliverable plans from the predicted doses rely on full
inverse optimizations using dose-volume histogram (DVH) objectives
derived from these doses. In this study, we aim to leverage deep learning
(DL) to rapidly generate machine delivery parameters for volumetric modulated arc therapy (VMAT) from predicted desired doses.
Materials/Methods: Data of 50 previously treated patients at our institution with prostate adenocarcinoma who received deﬁnitive radiotherapy
were retrospectively obtained. All plans were generated with a one-arc
VMAT technique, with conventional fractionation (78 Gy in 39 fx or 79.2
Gy in 44 fx to the prostate gland +/- seminal vesicles). A multi-task U-Net
was constructed: it takes the 2D projections of the 3D dose and planning
structures as inputs, and it predicts the numerical multi-leaf collimator
(MLC) sequence and weights for the 178 control points. Five cases were
randomly selected for testing only, and the remaining 45 formed the training set. The algorithm was implemented in Python 3.8 with PyTorch 1.7 as
the DL framework. Model training was performed on a GPU. The DL-predicted plans underwent further inverse optimization with the 3D-dosederived DVH objectives, utilizing only the last step of the Photon Optimizer (PO) in a treatment planning system. The optimization time and
plan quality were compared to plans generated with one full PO optimization with the same objectives and clinical plans (all normalized to
D95%=100% Rx dose).
Results: The DL model was trained for 200 epochs. On average, DL-predicted plans could be optimized in 22% (range, 18-26%) of the time
required for full optimization plans. Dosimetric comparison (Table 1) demonstrated that the quality of the DL-predicted plans was comparable with
clinical plans and full optimization plans, but the DL-predicted plans
tended to have increased dose inhomogeneity within the PTVs.
Conclusion: We demonstrated the feasibility of rapidly generating deliverable VMAT plans from desired 3D doses with deep learning. Further work
is needed to improve PTV dose homogeneity and generalize the method to
multi-arc VMAT delivery.
Abstract 3306 - Table 1
Metric

Clinical plan

DL-predicted
plan

Full Optimization
plan

Time for optimization
(seconds)

N/A

40+/-15

182+/-71

PTV, Max

109+/-2 %
Rx dose

113+/-2 %
Rx dose

108+/-1 %
Rx dose

PTV, D95%

100% Rx dose

100% Rx dose

100% Rx dose

Rectum, D15% (Gy)

65.0 +/- 6.9

66.8 +/- 6.3

64.7 +/- 6.9

Rectum, D25% (Gy)

55.0 +/- 7.1

57.5 +/- 6.9

54.8 +/- 8.4

Rectum, D50% (Gy)

40.6 +/- 7.0

41.6 +/- 6.8

39.7 +/- 8.2

Bladder, D15% (Gy)

60.0 +/- 18.8

61.0 +/- 19.3

59.4 +/- 20.4

Bladder, D25% (Gy)

47.0 +/- 22.4

46.9 +/- 23.4

48.0 +/- 23.8

Bladder, D35% (Gy)

35.0 +/- 22.4

35.0 +/- 22.8

35.4 +/- 23.2

Penile bulb, Mean (Gy)

43.4 +/- 22.7

44.2 +/- 24.0

42.4 +/- 23.3
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Registrations Using Atlas for Adaptive Radiotherapy of
Lung Cancer

3308

S.R. Alam,1 S. Meyer,1 L. Kuo,2 Y.C. Hu,1 W. Lu,1 E.D. Yorke,2 A. Rimner,3
L.I. Cervino,2 and P. Zhang2; 1Memorial Sloan Kettering Cancer Center,
New York, NY, 2Department of Medical Physics, Memorial Sloan Kettering
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Purpose/Objective(s): Evaluating the uncertainty of deformable image
registration (DIR) is challenging because the ground truth is often unavailable. We developed an automated method to create realistic deformations
via an atlas and assess DIR algorithms on a patient-speciﬁc level for adaptive radiotherapy.
Materials/Methods: A library of deformations was created by extracting
the longitudinal anatomical changes observed from an atlas of 60 locally
advanced non-small cell lung cancer patients treated with IMRT (60Gy, 30
fx). The deformation vector ﬁeld (DVF) between the planning CT (pCT)
and last weekly CBCT of an atlas patient was derived via a free-form DIR
algorithm and served as a ground truth pattern. An inquiry patient was ﬁrst
matched to an atlas patient on gross tumor volume (GTV) location and
volume. The pCT of an inquiry patient was then deformably registered to
that of an atlas patient to establish a voxel-based correspondence. Then,
the deformation pattern of the atlas patient was transferred to the inquiry
patient pCT by applying the known DVF to the corresponding voxels,
resulting in a digital CT phantom. Subsequently, this CT phantom was
appended with CBCT artifacts using a physics-based augmentation (Alam,
PMB 2021) to imitate a weekly CBCT. To evaluate DIRs, a large deformation diffeomorphic metric mapping (LDDMM) algorithm, and two commercial systems (C1 C2) were used between the phantom (both simulated
CT and CBCT) and actual pCT of the inquiry patient. Derived DVFs were
compared to the ground truth. The voxel-level geometric and dosimetric
uncertainties of DIRs were calculated using the DVF95% errors, fraction of
volume with ≤1.5mm errors (V1.5mm) and mean dose errors (Dmean) for
GTV and esophagus.
Results: In a retrospective evaluation of 10 paired inquiry and atlas
patients, the actual deformations observed between the pCT and weekly
CBCTs of inquiry patients were well-contained by the combined patterns
from the matched atlas, validating the feasibility of an atlas. LDDMM performed consistently well, especially for the CT-CBCT registration (p<0.01,
two-tailed t-test). GTV mean dose is less sensitive to DIR errors than
esophagus mean dose.
Conclusion: It is feasible to augment anatomical changes for a particular
inquiry patient using deformation patterns from matched patients in an
atlas and evaluate the uncertainty of DIR algorithms in realistic simulations. Integration of such an automated program facilitates the clinical
implementation of adaptive radiotherapy that involves longitudinal imaging studies.
Abstract 3307 − Table 1
CT-CT

CT-CBCT

DIR evaluation criteria

LDDMM

C1

C2

LDDMM

C1

C2

GTV

98§3

96§6

60§22

93§6

61§29

44§19

DVF95% (mm)

0.9§0.5

1.5§1.4

4.4§2.1

1.6§0.6

4.1§2.3

5.1§1.9

Dmean (cGy)

3§2

6§7

26§11

9§4

18§8

31§14

ESO

V1.5mm (%)

V1.5mm (%)

96§7

99§1

52§30

78§12

66§24

31§27

DVF95% (mm)

0.7§0.4

0.5§0.2

3.2§1.1

2.9§1.5

4.8§3.8

5.3§1.6

Dmean (cGy)

25§16

21§11

153§88

95§24

112§46

192§113

Feasibility of Using a Deep Learning Auto-Segmentation
Software Trained with Planning CT for Iterative CBCT Based
Online Adaptive Prostate Treatment
J. Duan,1 M.E. Bernard,1 J. Latorre,1 X. Feng,2 and Q. Chen1; 1University of
Kentucky, Lexington, KY, 2Carina Medical LLC, Lexington, KY
Purpose/Objective(s): Cone-beam CT (CBCT) based organs-at-risk
(OARs) delineation is the prerequisite of online adaptive therapy (ART)
which can be time-consuming and inefﬁcient. Auto-segmentation on
CBCT would reduce the extra clinical resources required, however, it is
labor-intensive to retrain the deep-learning auto-segmentation (DLAS)
with CBCT contours that need to be labeled. Over standard CBCT, iterative
CBCT (iCBCT) yields higher quality images with reduced noise and artifacts. This study aimed to comprehensively evaluate the feasibility of DLAS
software trained with planning CT for iCBCT based online adaptive prostate treatment.
Materials/Methods: Total 25 male pelvis iCBCTs from corresponding
prostate patients were selected for this study. An automated treatment
planning process was established to simulate the online ART procedure by
combining CT-based commercial DLAS software (i.e., trained with planning CT) and knowledge-based treatment planning used to eliminate
human bias. Prostate and surrounding critical structures (i.e., bladder,
rectum, and femoral heads) were delineated on iCBCT by a CT-based
DLAS and by manual modiﬁcation from corresponding planning CT
registration. The geometrics metrics of OARs were computed between
DLAS contours and manual contours. The prostate, considered as the
gross tumor volume (GTV), was manually modiﬁed from DLAS to pursue accurate target dose coverage. For each iCBCT, two VMAT plans of
70 Gy with two full arcs were generated using the manual contour sets
and DLAS contour sets respectively, which share the same modiﬁed
prostate contour. Both plans were normalized to 100% of the prescription dose to cover 98% of the planning target volume (PTV) derived
from GTV. The dose distributions from two plans were evaluated on
the manual structure sets. The clinical appropriateness was evaluated by
assessing D15(Gy), D25 (Gy), D35(Gy), and D50 (Gy) of critical structures following the RTOG-0815. The time required for the automated
treatment planning process was recorded.
Results: Average dice agreement for bladder, rectum, femoral head_L and
femoral head_R were 0.87 § 0.10, 0.82 § 0.08, 0.91 § 0.12, and 0.93 §0.07
respectively. DLAS generated a statistically signiﬁcant of 0.39 Gy greater on
bladder D25 than its counterpart. No statistically signiﬁcant differences were
found in other OARs dosimetric metrics. All unmodiﬁed OARs satisﬁed the
dose constraints of RTOG-0815 even with some artifact cases involved. The
average time needed for the automated treatment planning process simulating
ART was 11.85 minutes including DLAS generated time (0.69 minutes), GTV
modiﬁed time (0.9 minutes), and plan generated time on CPU (10.26 minutes).
Conclusion: The proposed DLAS trained with planning CT is a promising
contouring solution for iCBCT-based intact prostate online ART in the clinic
with labor shortage. Without modiﬁcation needed, it can generate clinically
acceptable OARs segmentation on iCBCT images within a limited time.
Author Disclosure: J. Duan: None. M.E. Bernard: University of Kentucky
Dept. Rad Med, NRG. J. Latorre: None. X. Feng: None. Q. Chen: Partner;
Carina Medical LLC. Research Grant; Varian Medical System. Consultant;
Reﬂexion Medical. Stock; Varian Medical System. Partnership; Carina
Medical LLC. create task group report on Tomotherapy QA practice;
AAPM. Carina Medical LLC.
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